Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload

In this retrospective analysis of a prospective RCT, deferiprone monotherapy was superior to deferoxamine for improvement in RVEF and end-systolic volume. This improvement in the RV volumes and function may contribute to the improved cardiac outcomes seen with deferiprone.